The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis-Reference-Cited by-同舟云学术

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis

Published:2021-01 Issue:1 Volume:8 Page:48-60
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Zinatizadeh Mohammad Reza^ORCID,Miri Seyed Rouhollah,Zarandi Peyman Kheirandish,Chalbatani Ghanbar Mahmoodi,Rapôso Catarina,Mirzaei Hamid Reza,Akbari Mohammad Esmaeil,Mahmoodzadeh Habibollah

Publisher

Elsevier BV

Subject

Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry

Reference190 articles.

1. RAS oncogenes: weaving a tumorigenic web;Pylayeva-Gupta;Nat Rev Cancer,2011

2. New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?;Bronte;Oncotarget,2015

3. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists;Kranenburg;Oncogene,2001

4. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins;Magalhaes;Br J Pharmacol,2012

5. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor;Ratner;Nat Rev Cancer,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage-Stimulating 1 Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease;Medicina;2024-07-31

2. Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo;Biochemical Pharmacology;2024-06

3. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways;Computers in Biology and Medicine;2024-05

4. The Impact of Cancer Stem Cells in Colorectal Cancer;International Journal of Molecular Sciences;2024-04-09

5. Revealing the active ingredients and mechanism of P. sibiricumm in non-small-cell lung cancer based on UPLC-Q-TOF-MS/MS, network pharmacology, and molecular docking;Heliyon;2024-04